KL070002

N/A

Report date: 2025/03/03 14:54:03
NME

Base Information

Drug NameKL070002
Drug Alias NameKL-070002
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionToxin CcdB inhibitors
TargetsToxin CcdB
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaDiscontinued
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A